logo
Whoop MG review: a wearable that makes sense of what all the data means for you

Whoop MG review: a wearable that makes sense of what all the data means for you

Irish Times15-05-2025

Whoop MG
    
Price
:
€399
Website
:
Where To Buy
:
Whoop
If there is one thing that wearable technology company Whoop knows how to do, it is health data. And now the company is set to expand on that, with not one but two new bands.
The first is the Whoop 5.0, an upgraded replacement for the standard band that has been around for a few years. The second is the Whoop MG, a device that is designed to give you even more data about your health, including an ECG, a blood-pressure monitor and additional heart screener capabilities.
If you are new to Whoop, all of this will mean very little, so first some backstory.
In 2015 Boston-based Whoop raised a shedload of money to create a wearable that would help athletes and their coaches gain insights into their training by taking data on key metrics – heart rate, heart rate variability, ambient temperature and movement – and crunching it into something more usable. It did this through the wearable strap, which was refreshingly screen-free, and the app, communicating all the data through Bluetooth.
READ MORE
A decade on, not much has changed. The Whoop band is still screen-free and the app is still a key part of the equation. Rory McIlroy is a fan. So is Cristiano Ronaldo. Whoop is doing pretty well for itself.
[
Wearable tech: 'It's like having a personal health coach in your pocket. I live a healthier, better life because I have this'
Opens in new window
]
But now Whoop tracks even more metrics, and gives you data on everything from your daily strain and recovery to hormonal insights.
Add in the ECG and blood-pressure features, and you have a fairly well-rounded device.
The new Whoop looks a lot like the old one at first glance. It is smaller, by about 7 per cent, but most people wouldn't notice the external differences unless they held the two sensors side by side and really scrutinised them.
The version reviewed here is the Whoop MG, which has one giveaway – the indents on the metal case that facilitate the ECG.
Rest your finger and thumb here to take an ECG. Although Whoop asks you to specify where you are wearing the band, I found it worked better on my left wrist. The right wrist resulted in a failed ECG every time.
Some of the features are immediately available. For example, the ECG can be taken and results fed back in 30 seconds, with the band screening for atrial fibrillation in the background.
Blood-pressure insights require calibration with a cuff to get an accurate measurement; three readings will get you started.
Whoop is clear that this is not a way to manage hypertension, however, so if you suffer with high blood pressure, you will still have to stick to your doctor's orders.
For the rest of us it will provide some information about what is going on internally, and maybe give some insight on how it is affecting our sleep and overall performance.
[
Xiaomi Watch S1 Pro: High-tech wearable with usual health features
Opens in new window
]
The Healthspan feature will require a bit more commitment. You need to wear the band for a few weeks, recording sleep data, before it will unlock. Then you can see not only your Whoop Age, but also your pace of ageing. Combined, the two quantify your long-term health.
Certain factors – sleep quality, exercise and so on – will affect the figures so you can see what your lifestyle is doing to your overall health in an easy-to-understand way. It also gives you tips on how to improve it. That will be a longer-term project, and outside the scope of this review.
With all these new elements come new subscription plans. Whoop One costs €199 per year and gives users fitness insights. Whoop Peak adds advanced health, fitness and longevity insights for €264 per year, while Whoop Life comes with medical-grade health and performance insights for €399 per year.
The Life subscription is the option for the Whoop MG; it works out at about €34 a month.
The Whoop MG is designed to appeal to those who want more information about their health and fitness, outside the standard athletic contingent that Whoop would once have targeted.
The question is why people would go for it over, say, a standard smartwatch that includes ECG (the Apple Watch) or blood-pressure monitoring (the Samsung Galaxy Watch) for a flat fee rather than a monthly subscription.
It depends on what you are looking for. Whoop's strength is its ability to take the data and give you feedback and tips on how to improve your health, rather than simply presenting you with some basic data and hoping you steer yourself in the right direction.
Good
The Whoop MG comes with some useful features, including the ECG and blood-pressure insights. It gives you data, but also tells you what it means, an area that I sometimes struggle with when it comes to other wearables.
Battery life is great, at more than two weeks, and the redesigned wireless battery pack you clip to the band to recharge it has also been tweaked to fit the smaller band.
Bad
If you don't like the idea of paying a subscription to access services, the Whoop band isn't for you. But with so many services turning to fees for additional insights, it is inevitable that we will end up paying someone, somewhere to tell us what all this data we are collecting means.
Everything else
New sensors mean new bands and new ways of wearing the sensors more discreetly. The Leatherluxe band makes the Whoop band more subtle, and you can also invest in some of the Whoop Body clothing.
Verdict
Whoop has added some valuable insights to its platform, but the ongoing subscription price may be a hurdle for some potential users.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dublin-based start-up Chemishield to create 50 jobs as firm eyes expansion into North America
Dublin-based start-up Chemishield to create 50 jobs as firm eyes expansion into North America

Irish Times

timean hour ago

  • Irish Times

Dublin-based start-up Chemishield to create 50 jobs as firm eyes expansion into North America

Dublin-based chemical waste start-up Chemishield says it plans to create 50 new jobs over the next 18 months as it expands into North America and seeks to grow its customer numbers and product offerings. The company runs a digital platform that helps organisations manage hazardous materials safely, ensure regulatory compliance and promote sustainability. It said the new roles will be across its Irish operations in sales, support and technology. The company has also announced that Malcolm Bell, chief executive of Envetec Sustainable Technologies, has invested in the group and joined its board of directors. Ford Chief Lisa Brankin on accelerating the switch to EVs Listen | 41:35 It said the investment represents 'an important new phase' for the company. Mr Bell's track record in business covers sectors such as healthcare, life sciences and sustainability. READ MORE 'He also spearheaded the implementation of clean technologies that enable global organisations to transition from outdated, traditional waste practices to circular, data-driven solutions for treating regulated medical waste,' the company said. Kevin Walsh, founder and chief executive of Chemishield, said Mr Bell's decision to join the company 'highlights the scale of the opportunity ahead'. 'We are changing how chemical and lab waste is managed at its source, and Malcolm's strategic insight, proven track record and experience scaling companies will be essential as we grow our platform and expand our partnerships,' he said. Mr Bell said Chemishield 'sits at the intersection of safety, sustainability and digital transformation'. 'With rising demand across essential industries, Chemishield is uniquely positioned to scale and set a new benchmark for compliance, safety, and operational efficiency,' he added. Chemishield's cloud-based platform replaces 'outdated, manual systems' with user-friendly digital tools that automate waste classification, regulatory labelling and compliance reporting in real time. It streamlines the disposal of hazardous and non-hazardous waste, 'ensuring safety and compliance', the group said. 'These features collectively contribute to a safer, more efficient and compliant laboratory environment.' The company focuses on key sectors, including pharmaceuticals, healthcare, life sciences and food and beverages.

Energia bid interest ranges from Japanese trading firm to private equity
Energia bid interest ranges from Japanese trading firm to private equity

Irish Times

time2 hours ago

  • Irish Times

Energia bid interest ranges from Japanese trading firm to private equity

The US owner of Energia received several first-round bids in advance of a deadline on Friday, after fielding interest from everyone from a Japanese trading company to North American private equity firms, said sources. New York-based investment firm I Squared Capital , which bought Energia, then known as Viridian Group, in 2016, pressed the start button on the long-awaited sale of the Irish electricity and gas utility in late March. The business is expected to achieve an enterprise value of €2.75 billion. Itochu Corporation, a Japanese trading company that is involved in businesses spanning textiles to energy and chemicals, US private equity giant KKR , and the Canada Pension Plan Investment Board are among parties that have been running the rule over Energia, according to sources. Australian financial services group Macquarie is also among the companies that have been circling the business, said the sources. READ MORE Spokeswomen for I Squared, KKR and Canadian pensions group and a spokesman for Energia declined to comment. It was not possible to secure comment from Itochu outside normal business hours in Japan, while a representative for Macquarie did not provide comment when contacted . Ford chief Lisa Brankin on accelerating the switch to electric vehicles Listen | 41:35 Reuters reported in recent days on the interest of Itochu and the Canadian Pension Plan Investment Board, which, it said, may ultimately team up with a UK electricity group in which it has a stake, Octopus Energy. It also said that Czech energy group EPH, French private equity firm Ardian and Spanish infrastructure investor Asterion were carrying out work on Energia with a view to making a bid. I Squared, founded 13 years ago by former executives at Morgan Stanley's infrastructure arm, acquired Energia in 2016 from Bahrain's Arcapita Bank for €1 billion. Arcapita had owned the business for almost a decade. The US firm subsequently sold a minority stake in Energia to an unknown investor the following year and set up a holding company over the business in the Cayman Islands. I Squared has made two unsuccessful efforts to sell the company before now, in 2018 and 2020. Energia, led by chief executive Ian Thom , reported in March that its earnings before interest, tax, depreciation and amortisation (Ebitda) dipped to €238.3 million for the nine months to the end of December from €246.7 million for the same period in the previous fiscal year. The three parts of Energia's business – renewable energy, a flexible electricity generation business and a unit supplying customers – have proven to be complementary in recent years despite upheaval across energy markets. An Bord Pleanála gave Energia permission in March to build a data centre in Huntstown, Co Dublin, in partnership with tech giant Microsoft, adding to the investment case for potential suitors. Energia also has a solar energy pipeline of more than 1,200MW.

New spying claims emerge in Silicon Valley corporate espionage scandal with Irish twist
New spying claims emerge in Silicon Valley corporate espionage scandal with Irish twist

Irish Times

time12 hours ago

  • Irish Times

New spying claims emerge in Silicon Valley corporate espionage scandal with Irish twist

A bitter fight over alleged corporate espionage involving two of Silicon Valley's hottest start-ups took a new twist on Tuesday, after $12 billion (€10.5 billion) HR software company Deel claimed arch-rival Rippling had directed one of its employees to 'pilfer' the company's assets by posing as a customer. The latest claim comes after Rippling alleged earlier this year that a Dublin-based staff member had been spying on behalf of Deel. The employee, Keith O'Brien, locked himself into a bathroom and smashed his phone with an axe when confronted with allegations, according to his own testimony. In new legal filings seen by the Financial Times, Deel has countered by arguing that: 'Rippling has been actively engaged in a carefully co-ordinated espionage campaign, through which it infiltrated Deel's customer platform by fraudulent means and pilfered the company's most valuable proprietary assets.' The case has exposed the increasingly bitter rivalry between the two San Francisco-based groups, backed by some of the Valley's top investors, who are competing in the typically staid world of workforce management software. READ MORE The two tech unicorns are backed by some of America's most high-profile start-up investors. Rippling was valued at $16.8 billion last month. Deel has sought to dismiss Rippling's initial claims of directing corporate espionage and has filed a lawsuit in Delaware alleging its rival is trying to impugn Deel's reputation. Its latest filings were lodged on Tuesday morning as an amendment in that case. It alleges that Brett Alexander Johnson, Rippling's 'competitive intelligence manager', posed as a customer and accessed details of Deel's products and business practices over the course of six months. That information was in turn used to build one of Rippling's products, Deel alleges. Deel's investigation 'remains in its nascent stages' but the company nonetheless claims it has 'unequivocal proof' of Mr Johnson's alleged activities. It also alleges that Rippling chief executive Parker Conrad encouraged Mr Johnson's activities with the intention of uncovering 'the secrets by which Deel has achieved years of profitability'. Rippling originally filed a suit against Deel in California in March. Deel has filed motions to dismiss that and move the case to Ireland. It has separately filed a civil lawsuit against Rippling in Delaware. The latest allegations are an amendment to the Delaware suit. The dispute stems from Rippling's claim in a March court filing that Deel had cultivated Mr O'Brien, a Rippling employee, to steal confidential business information over a four-month period. 'The highest levels of Deel's leadership are implicated in a brazen corporate espionage scheme and they will be held accountable,' said Alex Spiro, legal counsel for Rippling, at the time. Mr O'Brien also said in his testimony that he was operating for Deel at the direction of chief executive Alex Bouaziz, Deel has suggested O'Brien, was in fact a whistleblower concerned with Rippling's business practices and claimed he provided testimony under duress. Rippling did not immediately respond to a request for comment. – Copyright The Financial Times Limited 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store